Clinical trial
Comparison of Emergence Agitation Between Remimazolam With Flumazenil and Propofol-based Total Intravenous Anesthesia in Patients Undergoing Nasal Surgery: A Randomized Controlled Trial
NCT07265050 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Emergence Agitation Between Remimazolam With Flumazenil and Propofol-based Total Intravenous Anesthesia in Patients Undergoing Nasal Surgery: A Randomized Controlled Trial
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 204 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
emergence agitation